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Abstract
Background: Werner Syndrome (WS) is a rare disorder characterized by the premature onset of a number of age-
related diseases. The gene responsible for WS encodes a DNA helicase/exonuclease protein believed to affect
different aspects of transcription, replication, and/or DNA repair. In addition to genomic instability, human WS cells
exhibit oxidative stress. In this report, we have examined the impact of exogenous hydrogen peroxide on the
expression profile of mouse embryonic fibroblasts lacking part of the helicase domain of the WRN homologue
(here referred to as Wrn
Δhel/Δhel).
Results: Wrn
Δhel/Δhel mutant mouse embryonic fibroblasts exhibit increased oxidative stress. This was reflected by
increased intracellular reactive oxygen species (ROS), increased oxidative damage in genomic DNA, changes in
ATP/ADP ratios, and a disruption of the inner mitochondrial transmembrane potential when compared to wild
type mouse embryonic fibroblasts. Expression profile analyses of hydrogen peroxide-treated wild type cells have
indicated significant decreases in the expression of genes involved in mitosis, glycolysis, fatty acid metabolism,
nucleic acid metabolism, and cell cycle control, as well as protein modification and stability. Such decreases in
these biological processes were not observed in hydrogen peroxide-treated Wrn
Δhel/Δhel cells. Importantly, untreated
Wrn
Δhel/Δhel cells already exhibited down regulation of several biological processes decreased in wild type cells that
had been treated with hydrogen peroxide.
Conclusion: Expression profiling of Wrn
Δhel/Δhel mutant cells revealed a very different response to exogenous
addition of hydrogen peroxide in culture compared to wild type cells. This is due in part to the fact that Wrn
Δhel/
Δhel mutant cells already exhibited a modest chronic intracellular oxidative stress.
Background
It is well established that increased levels of reactive oxy-
gen species (ROS) are involved in a number of diseases
including diabetes, complications from obesity, athero-
sclerosis, and cancer [1-3]. A major source of endogen-
ous ROS comes from the mitochondria during the
process of oxidative phosphorylation to produce energy
in the form of ATP. In addition, ROS are produced by
intracellular membrane oxidases following stimulation
either with platelet-derived growth factors, TNF-a,o r
insulin [1-3]. Inflammation is also a major source of ROS
at sites of tissue fibrosis [1-3]. It is thus important for the
cell to rapidly neutralize ROS before they can damage
cellular macromolecules including DNA. A major DNA
lesion generated by excessive ROS is 8-oxo-2’-deoxygua-
nosine, which leads to a single or double strand break
when left unrepaired [4]. Persistent breaks can in turn
lead to genomic instability. It is widely believed that the
accumulation of mutations is a main cause of several
aging processes [5]. In addition, oxidative stress is known
to shorten telomeres [6] a process likely leading to repli-
cative senescence and aging as well [7]. Thus, an abnor-
mal response to constant increased levels of endogenous
intracellular ROS would likely affect aging [8,9].
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modulate multiple aspects of aging. They are referred as
segmental progeroid syndromes. A common feature of
all progeroid syndromes is genomic instability. One
such syndrome is Werner syndrome (WS) also known
as “Progeria of the Adult” [10]. WS is an autosomal
recessive disorder characterized by genomic instability
and the premature onset of a number of age related dis-
eases [11,12]. The gene responsible for WS (WRN)w a s
identified by positional cloning and encodes a protein
containing a RecQ-type helicase consensus domain [13].
It was subsequently found that, in addition to a 3’-5’
helicase activity, the WRN protein also possesses a 3’-5’
exonuclease activity [14,15]. It has been recently pro-
posed that WRN protein may be required for the repair
of oxidative DNA damage [16] including oxidative DNA
damage at telomeres [17].
Remarkably, increased oxidative stress was described
for WS patients [18]. Furthermore, human WS fibro-
blasts exhibit increased intracellular oxidized protein
content [19]. Increased oxidative stress was also
observed in embryonic cells derived from mice lacking
part of the helicase domain [20]. In this study, we
sought to determine the impact of additional oxidative
stress in mouse embryonic fibroblasts lacking part of
the helicase domain of the WRN gene ortholog. Expres-
sion profiling analyses of Wrn
Δhel/Δhel mutant cells
revealed a very different response to addition of hydro-
gen peroxide in culture compared to wild type cells as
they already exhibit a modest but significant chronic
increase in intracellular ROS levels.
Results
Oxidative stress in Wrn
Δhel/Δhel mouse embryonic
fibroblasts
Previous data have indicated that Wrn
Δhel/Δhel mouse
embryonic fibroblasts acquire a slower growth rate than
wild type fibroblasts with the number of passages in cul-
ture [21]. In addition, Wrn
Δhel/Δhel mutant cells exhibit
increased chromosomal rearrangements with the num-
ber of passages in culture [22]. As oxidative DNA
damage can lead to chromosomal rearrangements, levels
of intracellular ROS and the extent of oxidative DNA
damage were measured in wild type and Wrn
Δhel/Δhel
embryonic fibroblasts. Intracellular ROS levels were
examined directly in mouse embryonic fibroblasts with
the dye 2’-7’ dichlorofluorescein diacetate. This dye is
highly fluorescent upon oxidation. Cells in the presence
of the dye were lysed and the extent of fluorescence
released from cells was measured with a fluorescence
spectrophotometer as described previously [23]. As
shown in Figure 1A, ROS levels were 10% higher in
Wrn
Δhel/Δhel cells (t-test; P < 0.05) compared to wild
type cells. Concomitantly, there were on average 51
abasic sites per pg of genomic DNA in wild type cells
and 64 abasic sites per pg of genomic DNA in Wrn
Δhel/
Δhel cells, a 20% increase in the mutant cells (t-test; P <
0.05) (Figure 1B). These results indicate that Wrn
Δhel/
Δhel cells exhibit a modest but significant increase in oxi-
dative stress.
Since a cellular redox change may decrease energy
production in the form of ATP from mitochondria, we
next examined intracellular ATP levels and mitochon-
drial membrane potential. As shown in Figure 1C, the
ATP level in Wrn
Δhel/Δhel mutant cells was 30% lower
than wild type cells. Consequently, the ADP/ATP ratio
in Wrn
Δhel/Δhel cells was approximately 30% higher than
wild type cells (Figure 1D). A lower ATP production
might be a consequence of disruption of the inner mito-
chondrial transmembrane potential in mutant cells. The
mitochondrial membrane potential was thus examined
in our mouse embryonic fibroblasts with the fluorescent
dye tetramethylrhodamine ethyl ester (TMRE) As indi-
cated in Figure 1E, fluorescence intensity was 30% lower
in Wrn
Δhel/Δhel cells compared to wild type cells (t-test;
P < 0.03). Taken together, these results indicate a distur-
bance of mitochondrial activities in Wrn
Δhel/Δhel mutant
cells.
Glutathione (GSH) is the principal intracellular low-
molecular-weight thiol and it plays a critical role in the
defense against oxidative stress in mammalian cells. We
wanted to know whether the abundance of this mole-
cule is affected in mutant cells. Levels of GSH were thus
quantified in our mouse wild type and Wrn
Δhel/Δhel
mutant embryonic fibroblasts. Remarkably, levels of
GSH were 151% higher in Wrn
Δhel/Δhel mutant cells
compared to wild type cells (t-test; P < 0.001) (Figure
2). These results suggest that Wrn
Δhel/Δhel mutant cells
display an adaptive response to oxidative stress. This
response was further examined by treating cells with
exogenous H2O2. Cells were treated one hour with 0.5
mM H2O2 and GSH levels were measured 24 hours
later. As indicated in Figure 2, H2O2 induced a 178%
increase in GSH levels in wild type cells (t-test; P <
0.001). There was no significant increase in GSH levels
in Wrn
Δhel/Δhel mutant cells. As indicated above GSH
levels were already high in untreated Wrn
Δhel/Δhel cells.
These results indicate that Wrn
Δhel/Δhel mutant cells
continuously exhibited an increased anti-oxidant
response.
Expression profiling of mouse embryonic fibroblasts
treated with H2O2
Little is known about the global response to H2O2 in wild
type and Wrn
Δhel/Δhel mouse embryonic fibroblasts. To
c o m p i l eal i s to fH 2O2-responsive genes, we compared
wild type cells before and after oxidative cellular stress.
Cells were treated with H2O2 for one hour, fed with fresh
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Hybridization was performed on Whole Mouse Genome
Agilent 60-mer Oligo Microarray chips (containing
approximately 44,000 probes) by mixing wild type Cy-3-
labeled cRNA (baseline expression levels) with H2O2-trea-
ted wild type Cy-5-labeled cRNA. Hybridization experi-
ments were performed twice with different wild type
biological replicates. The same strategy was adopted for
Wrn
Δhel/Δhel mutant cells. Hybridization was performed by
mixing untreated Wrn
Δhel/Δhel mutant Cy-3-labeled cRNA
with H2O2-treated Wrn
Δhel/Δhel Cy-5-labeled cRNA.
Lists of genes differentially expressed were generated
by requiring that the absolute value of the fold change
be higher than two, that the log2 of the expression level
(or signal) for each gene be higher than six, and the
adjusted P-value, using the Benjamini-Hochberg
method, be lower than 0.005. Six hundred and seventy
eight genes exhibited a two-fold alteration in mRNA
expression level in H2O2-treated wild type mouse
embryonic fibroblasts compared to untreated wild type
cells (548 down-regulated and 130 up-regulated, respec-
tively) (additional file 1). Four hundred and twenty one
Figure 1 Increased oxidative stress in mutant mouse embryonic fibrobasts. (A) ROS levels in wild type and Wrn
Δhel/Δhel cells determined by
measuring the intensity of fluorescence by 2’,7’-dichlrofluorescein per μg of protein in cells. Asterisks denote statistical significance compared to
wild type cells (*t-test: P < 0.05). (B) Oxidative DNA lesions created by ROS in wild type and Wrn
Δhel/Δhel cell cultures. The number of abasic sites
per pg of genomic DNA was detected as described in Materials and Methods. The asterisk denotes statistical significance compared to wild type
cells (*t-test: P < 0.05). (C) ATP levels in wild type and Wrn
Δhel/Δhel cells. Asterisks denote statistical significance compared to wild type cells (*t-
test: P < 0.05). (D) ADP/ATP ratios in wild type and Wrn
Δhel/Δhel cells. Asterisks denote statistical significance compared to wild type cells (*t-test: P
< 0.05). (E) Inner mitochondrial transmembrane potential in wild type and Wrn
Δhel/Δhel cells. Mitochondrial membrane potential was measured
with the potentiometric dye TMRE. Asterisks denote statistical significance compared to wild type cells (*t-test: P < 0.03). All experiments in this
figure were performed in quadruplicate.
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H2O2-treated Wrn
Δhel/Δhel mouse embryonic fibroblasts
compared to untreated Wrn
Δhel/Δhel cells (368 down-
regulated and 53 up-regulated, respectively) (additional
file 2). One hundred and seventy five genes were altered
in both H2O2-treated wild type and Wrn
Δhel/Δhel mouse
embryonic fibroblasts (Figure 3A and additional file 3).
Real time RT-PCR was performed on seven randomly
picked genes from the untreated versus H2O2-treated
wild type mouse embryonic fibroblasts data (additional
file 1) to confirm our microarray analyses (Table 1). A
list of the primers for the genes analyzed is shown in
the additional file 4. Overall, the fold changes observed
by real time RT-PCR were in good agreement with the
predicted fold changes from the microarray data high-
lighted by a significant Spearman’s correlation (rho =
0.9286; P = 0.0067).
The PANTHER classification system was used to classify
differentially expressed genes by their functions in speci-
fic biological processes. Categorization of the genes in
our lists revealed 23 and 5 significantly down regulated
biological processes (with a Benjamini value of less than
0.05) for wild type and Wrn
Δhel/Δhel mouse embryonic
fibroblasts treated with H2O2, respectively (Figure 3).
Four processes were commonly down regulated in wild
type and Wrn
Δhel/Δhel mouse embryonic fibroblasts trea-
ted with H2O2 and they include genes involved in cation
transport, chromatin remodeling, cell motility, and
developmental processes (or cellular differentiation)
( F i g u r e3 Ba n d3 C ) .T h eo n l ya dditional biological pro-
cess that was down regulated in Wrn
Δhel/Δhel mouse
embryonic fibroblasts corresponded to the cellular
defense response requiring antigen presentation during
major histo-compatibility complex II molecule (MHCII)-
mediated immunity. Wild type mouse embryonic fibro-
blasts treated with H2O2 also exhibited decreases in bio-
logical pathways affecting protein and vesicle
transportation, cell surface mediated signal transduction,
cell cycle and proliferation, nucleic acid metabolism,
several types of protein modification and folding, pro-
teolysis, glycolysis, and mitosis (Figure 3C). Finally,
based on PANTHER analysis no biological pathway was
significantly up regulated in either H2O2-treated wild
type or H2O2-treated Wrn
Δhel/Δhel mouse embryonic
fibroblasts.
Several biological processes are already decreased in
untreated Wrn
Δhel/Δhel mouse embryonic fibroblasts
We also performed PANTHER analysis on the list of
genes differentially expressed between untreated wild
type and untreated Wrn
Δhel/Δhel mouse embryonic fibro-
blasts. Differentially expressed genes between Wrn
Δhel/
Δhel and wild type mouse embryonic fibroblasts were
selected by requiring that the log2 of the expression
level for each gene be higher than six and the adjusted
P-value, using the Benjamini-Hochberg method, be
lower than 0.005 (additional file 5). Figure 4A indicates
that biological processes such as protein folding, protein
metabolism and modification, proteolysis, G-protein-
mediated signaling, cation transport, and developmental
processes were significantly down regulated in Wrn
Δhel/
Δhel mouse embryonic fibroblasts compared to wild type
cells (with a Benjamini value < 0.05). Purine metabo-
lisms, as well as amino acid metabolism and biosynth-
esis processes, were up regulated in Wrn
Δhel/Δhel mouse
embryonic fibroblasts compared to wild type cells.
These results indicate that all the biological processes
down regulated in untreated Wrn
Δhel/Δhel mouse
embryonic fibroblasts (compared to untreated wild type
cells) were also down regulated in H2O2-treated wild
type mouse embryonic fibroblasts (Figure 4B).
Discussion
We have previously observed increased oxidative stress
in mouse embryonic fibroblasts established from
Figure 2 Reduced GSH levels in H2O2-treated and untreated
wild type and Wrn
Δhel/Δhel mouse embryonic fibroblasts
determined by the intensity of fluorescence per μg of protein.
Fluorescence of reduced GSH was detected with the ApoGSH
glutathione detection kit (Bio Vision Mountain View, CA). Oxidative
stress was induced by treating cells with 0.5 mM H2O2 one hour
and fresh medium was then added for an additional 24 hours to
allow the cells to recover before measurements. (*t-test: P < 0.001
compared to untreated wild type mouse embryonic fibroblasts).
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Δhel/Δhel mice compared to wild type cells [20]. In
this study, we further explored this phenotype by exam-
ining the expression profile of such cells. Wrn
Δhel/Δhel
mutant cell lines exhibited a 10% increase in ROS levels
compared to wild type cells (baseline level). Importantly,
the high levels of GSH in Wrn
Δhel/Δhel mutant cells con-
firmed indirectly the increased oxidative stress in such
cells. In fact, GSH levels in Wrn
Δhel/Δhel mutant cells
were almost as high as wild type cells that had been
treated with exogenous H2O2 (Figure 2). Further analy-
sis of cells with the potentiometric dye TMRE has indi-
cated a lower mitochondrial transmembrane potential in
Wrn
Δhel/Δhel mutant cells. At the same time, we detected
a lower amount of ATP in the mutant cells compared
to wild type cells. Production of lower quantities of ATP
by mitochondria may in part be responsible for the slow
growth phenotype associated with Wrn
Δhel/Δhel cells
[20]. The increase in ROS concomitant with the high
Figure 3 Distinct biological processes significantly altered by H2O2 in Wrn
Δhel/Δhel and wild type mouse embryonic fibroblasts. (A) Venn
diagrams showing the number of genes overlapping between Wrn
Δhel/Δhel and wild type mouse embryonic fibroblasts treated with H2O2. (B)
Histogram representing all the biological processes significantly down regulated by H2O2 in Wrn
Δhel/Δhel mouse embryonic fibroblasts. (C)
Histogram representing all the biological processes significantly down regulated by H2O2 in wild type mouse embryonic fibroblasts. Biological
processes with a Benjamini value less than 0.05 are presented in each histogram (as the -log10 of the Benjamini value). The black bars in each
histogram represent the cellular processes commonly affected in both Wrn
Δhel/Δhel and wild type mouse embryonic fibroblasts.
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by mitochondria in Wrn
Δhel/Δhel mouse embryonic fibro-
blasts are consistent with the phenotypes observed in
the liver tissue of Wrn
Δhel/Δhel mice [24]. Wrn
Δhel/Δhel
mice exhibit increased GSH levels in liver tissue with
increased ROS, DNA damage and decrease ATP levels
with age. These results suggest that the observed
anomalies in the Wrn
Δhel/Δhel mice are observable at the
cellular level with mouse embryonic fibroblasts in cul-
ture. Such results suggest that cells in a given tissue
already exhibit a modest but chronic intracellular pro-
oxidative status. In accord with this, a pro-oxidative sta-
tus has been described for WS patients [18].
Our prediction was that an exogenous addition of
ROS to Wrn
Δhel/Δhel mutant cells would exacerbate the
intracellular metabolic anomalies and damage as the
anti-oxidative system of such cells is already saturated
(at least for the GSH system) while coping with a
chronic higher intracellular level of ROS. The results
obtained with mouse embryonic fibroblasts treated with
an exogenous source of H2O2 are highly relevant since
additional ROS at the tissue level may follow each meal
due to increased sugar and lipid levels in the blood
stream after ingestion. Increased sugar and lipids will
potentially impact on the cellular redox status of cells in
several tissues [25,26].
The impact of H2O2 on the expression profile of Wrn
mutant cells has not been previously analyzed. Microar-
ray analyses indicated that Wrn
Δhel/Δhel mouse embryonic
fibroblasts respond very differently from wild type cells
to exogenous H2O2. These results are consistent with the
observation that human WS cells respond differently to
H2O2 when compared to cells with a functional WRN
gene product [27,28]. Again, this difference maybe due to
the fact that cells with a mutation in the Wrn gene are
already exhibiting chronic increased oxidative stress in
culture [20,29]. Significant decreases in the expression of
genes involved in mitosis, glycolysis and fatty acid meta-
bolism (energy production), nucleic acid metabolism, cell
cycle control, as well as protein modification and stability
were observed in H2O2-treated wild type embryonic
fibroblasts. Such dramatic decreases in these biological
processes were not observed in H2O2treated Wrn
Δhel/Δhel
cells. Interestingly, untreated Wrn
Δhel/Δhel cells already
exhibited changes in several of these biological processes
Table 1 Correlation of the real time RT-PCR-derived
values with the microarray data from wild type mouse
embryonic fibroblasts treated with peroxide.
Gene Fold change in
microarray
Fold change
from RT-PCR
Ero1L (endoplasmic reticulum
oxidoreductase 1-like)
+2.84 +2.76
Fn1 (fibronectin-1) -2.19 -1.45
Mt1 (metallomethionin-1) +2.25 +1.71
Mt2 (metallomethionin-2)
Nqo1 (NAD(P)H
dehydroxygenase, quinone 1)
+2.68 +1.65
Txnrd1 (thioredoxin reductase 1) +2.06 +1.63
Uchl1 (ubiquitin carboxy-
terminal hydrolase L1)
+3.72 +7.97
Spearman’s correlation between microarray and RT-PCR data: rho = 0.9286;
p-value = 0.0067
Figure 4 Histogram indicating the major biological processes
in untreated Wrn
Δhel/Δhel mouse embryonic fibroblasts
significantly changed compared to untreated wild type cells.
(A) The biological processes with a Benjamini value less than 0.05
are presented for untreated Wrn
Δhel/Δhel mouse embryonic fibroblasts
versus untreated wild type cells (baseline level) as the -log10 of the
Benjamini value. The black and gray bars represent the up and
down regulated cellular processes, respectively. (B) Venn diagrams
showing the number of down regulated biological processes
overlapping between untreated Wrn
Δhel/Δhel and H2O2-treated wild
type mouse embryonic fibroblasts.
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oxidative stress in these mutant cells. A likely deleterious
consequence of responding differently to additional ROS
is a greater increase in the presence of persistent DNA
breaks and the rapid accumulation of chromosome rear-
rangements compared to wild type mouse embryonic
fibroblasts [22].
The International Registry of Werner Syndrome
http://www.wernersyndrome.org has provided molecular
diagnosis of WS for over a decade. Fifty distinct muta-
tions inactivating the WRN protein have been described
in WS patients to date [30]. These mutations include
missense and nonsense substitutions, frame shifts and
premature translation termination mutations, deletions
and insertions. All these mutations are believed to dis-
rupt the normal function of WRN protein or to cause a
truncation of the protein that cannot localize to the
nucleus, the normal site of WRN protein action. Some
mutations also cause abnormally rapid degradation of
the WRN protein. Our mouse model has an in-frame
deletion in the helicase domain of the Wrn protein,
which is as stable as the normal protein [31]. However,
the mutant protein does not stably interact with the
DNA replication complex [32] suggesting that this
mutation in mouse severely affects the overall function
of the mutant Wrn protein. Although thorough bio-
chemical analyses of this mutant protein are required,
the Wrn helicase mutant mice provide a compelling
model as they exhibit most metabolic abnormalities
observed in human WS patients [23,24].
Conclusion
To conclude, untreated Wrn
Δhel/Δhel mutant cells exhibit
increased ROS generation due to alterations in mito-
chondrial activities. The exact reason for such mito-
chondrial alterations is unknown but mitochondrial
dysfunction is well known to lead to physiological
decline with age [9]. We recently observed that a transi-
ent knock down of WRN protein in human fibroblasts
is sufficient to change the expression of genes involved
in lipidogenesis [33]. Such changes are known to affect
the redox status in cells, which in turn affects mitochon-
drial function [34]. Interestin g l y ,w eh a v ea l s oo b s e r v e d
that Wrn
Δhel/Δhel mutant mice exhibit increased rate of
point mutations in the mitochondrial DNA of liver and
heart tissues [24], which can potentially lead to further
mitochondrial dysfunction with age. Finally, a transient
knock down of WRN in human fibroblasts will increase
the activity of several protein kinase C enzymes includ-
ing PKCδ [29]. PKCδ is known to modulate ROS pro-
duction from mitochondria [35]. Hence, there is the
interesting possibility that depletion of WRN activates
PKCδ, which in turn modulates ROS production from
mitochondria. Indeed, a decreased production of ROS in
WRN-depleted fibroblasts can be observed by knocking
down PKCδ protein levels in such cells. Future appro-
priate experiments will determine which pathways, tran-
scription regulation of specific metabolic genes or
activation of specific kinases, are responsible for the
redox imbalance seen in human WRN mutant or mouse
Wrn
Δhel/Δhel cells.
Methods
Primary mouse embryonic fibroblasts and RNA
Mice lacking part of the helicase domain of the Wrn gene
were generated by homologous recombination in mouse
embryonic stem cells [31]. In the process, 121 amino acid
residues of the Wrn protein were deleted (amino acids
710 to 831). The genetic background of these mice was
both 129/Sv and Black Swiss (129/Sv/Black Swiss genetic
background). Care of mice was in accordance with the
guidelines of the Committee for the protection of animals
at the Université Laval. Generation and maintenance of
the embryonic cells has been described previously [21].
Briefly, healthy 15.5-day old embryos were minced in
6-well plates and maintained in low glucose DMEM sup-
plemented with 10% heat-inactivated calf serum at 37°C
in an atmosphere of 5% CO2. Adherent cells established
from embryonic tissues were passaged as soon as they
reached confluence. Cytoplasmic RNA was extracted
according to standard protocols [36]. After DNAse treat-
ment and phenol:chloroform extraction, precipitated
cytoplasmic RNA was dissolved in RNase-free water and
purity was verified with an Agilent 2100 bioanalyzer
(Agilent, Palo Alto, CA).
Microarray analysis
Duplicated biological RNA samples (wild type versus
H2O2-treated wild type; Wrn
Δhel/Δhel versus H2O2-treated
Wrn
Δhel/Δhel cells; wild type versus Wrn
Δhel/Δhel)w e r e
labeled with Cyanin-3 or -5 labeled CTP (PerkinElmer,
Boston, MA). Labeled cRNAs were purified using the
RNeasy Mini kit (Qiagen, Mississauga, ON) and were
hybridized onto Whole Mouse Genome Agilent 60-mer
Oligo Microarrays (44,000 probes/microarray) using the in
situ Hybridization Plus kit (Agilent, Palo Alto, CA) follow-
ing the manufacturer’s instructions. Arrays were scanned
using a dual-laser DNA microarray scanner. Data were
then extracted from images by the Feature Extraction soft-
ware 6.1 (Agilent, Palo Alto, CA). Lists of differentially
expressed genes were generated using limma in BioCon-
ductor http://www.bioconductor.org. The data were back-
ground subtracted and normalized using the loess
method. Correction for multiple hypothesis testing was
performed using the Benjamini-Hochberg method. We
have deposited all the raw data in the NCBI public data-
base Gene Expression Omnibus http://www.ncbi.nlm.nih.
gov/geo/ [accession series number GSE19007].
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The PANTHER (Protein ANalysis THrough Evolutionary
Relationships) classification system is a unique resource
that classifies genes by their functions, using published
scientific experimental evidence and evolutionary rela-
tionships to predict function even in the absence of direct
experimental evidence. Proteins are classified by expert
biologists into families and subfamilies of shared func-
tion, which are then categorized by molecular function
and biological process ontology terms. This program is
implemented in the DAVID (Database for Annotation,
Visualization, and Integrated Discovery) web site [37].
Enrichments for specific biological functions using
PANTHER were considered significant with a Benjamini
value smaller than 0.05. The Benjamini value corresponds
to an adjusted p-value using the Benjamini-Hochberg
method to correct for multiple hypotheses tested during
gene enrichment analyses.
Measurements of reactive oxygen species
Mouse embryonic fibroblasts were incubated with 10
μg/μlo ft h ed y e2 ’-7’ dichlorofluorescein diacetate
(Sigma-Aldrich Canada Ltd., Oakville, ON) for one hour
at 37°C. This dye is highly fluorescent upon oxidation.
After this incubation time, cells were harvested and
lysed in RIPA buffer [50 mM Tris-HCl (pH 7.5), 150
mM NaCl, 1% NP-40, 0.1% SDS, 0.5% sodium deoxy-
cholate] for 10 minutes. Cell debris were spun down
and 100 μl of lysate was transferred to 96-well plates for
fluorescence measurements with a Fluoroskan Ascent
fluorescence spectrophotometer (Thermo Electron Inc.,
Milford, MA). The excitation and emission wavelengths
used were 485 nm and 527 nm, respectively. The final
result was expressed as units of fluorescence per μgo f
proteins. Protein concentrations were measured using
the Bradford assay.
Measurements of oxidative DNA damage
DNA was extracted from mouse embryonic fibroblasts
w i t ht h eD N e a s yT i s s u eK i t( Q i a g e nI n c . ,M i s s i s s a u g a ,
ON) according to the manufacturer’s protocol. Abasic
sites in genomic DNA were quantified with the Oxida-
tive DNA Damage Kit from Kamiya Biomedical Com-
pany (Seattle, WA). Briefly, this kit contains an aldehyde
reactive reagent (N’-aminooxymethylcarbonylhydrazino-
D-biotin), which reacts with the open ring form of
apurinic sites in DNA. Oxidative attack by hydroxyl
radicals on the deoxyribose moiety will lead to the
release of free bases from DNA, generating abasic or
apurinic sites. The aldehyde reagent will thus tag apuri-
nic sites with biotin. The number of biotin-tagged apuri-
nic sites was quantified using conjugated avidin-horse
radish peroxidase followed by a colorimetric detection
of peroxidase.
Measurements of reduced glutathione
Intracellular levels of glutathione (GSH) were quantified
with the ApoGSH Glutathione Detection Kit from Bio
Vision (Mountain View, CA). The assay utilizes mono-
chlorobimane (MCB), a dye that appears to form
adducts exclusively with GSH. The GSH-bound MCB
dye fluoresces blue. Fluorescence was measured with a
Fluoroskan Ascent fluorescence spectrophotometer
(Thermo Electron Inc., Milford, MA). The excitation
and emission wavelengths used were 355 nm and 460
nm, respectively.
Measurements of ATP and ADP
Intracellular levels of ATP and ADP were quantified
with the ApoSensor ADP/ATP ratio assay kit from Bio
Vision (Mountain View, CA). The assay utilizes the
enzyme luciferase to catalyze the formation of light
from ATP and luciferin. ADP levels are measured by
conversion to ATP that is subsequently detected using
the same reaction. Luminescence was measured with a
Luminoskan Ascent luminometer (Thermo Electron
Inc., Milford, MA).
Measurements of inner mitochondrial transmembrane
potential
The inner mitochondrial transmembrane potential of
mouse embryonic fibroblasts was determined using tet-
ramethylrhodamine ethyl ester (TMRE). Cells were incu-
bated in a culture medium containing 100 μMT M R E
for 15 min in the dark at 37°C. Fresh medium was then
added after washing cells twice with PBS to remove
extracellular TMRE. Cells were harvested and fluores-
cence intensity of TMRE was detected with a Fluoros-
kan Ascent fluorescence spectrophotometer (Thermo
Electron Inc., Milford, MA). The excitation and emis-
sion wavelengths used were 544 nm and 590 nm,
respectively.
Statistical analysis
Data are presented as means ± SEM. The unpaired Stu-
dent’s t-tests were all performed using two-tailed hypoth-
esis and equal variance. Differences between classes were
considered significant at P-value lower than 0.05 in all
statistical analyses. All statistical analyses were performed
with R version 2.6.0 http://www.r-project.org.
Additional file 1: Differential expression profile between untreated
and H2O2-treated wild type mouse embryonic fibroblasts. This table
is listing the genes altered more than 2 times with a Benjamini-
Hochberg adjusted p-value lower than 0.1 while comparing the H2O2
treated versus non-treated wild type mouse embryonic fibroblasts.
Complete results of microarray analyses are found in additional files 1, 2,
4, and 5.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
127-S1.XLS]
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Page 8 of 10Additional file 2: Differential expression profile between untreated
and H2O2-treated Wrn helicase mutant mouse embryonic
fibroblasts. This table is listing the genes altered more than 2 times
with a Benjamini-Hochberg adjusted p-value lower than 0.1 while
comparing the H2O2 treated versus non-treated Wrn helicase mutant
mouse embryonic fibroblasts. Complete results of microarray analyses are
found in additional files 1, 2, 4, and 5.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
127-S2.XLS]
Additional file 3: Genes commonly altered in both H2O2-treated
wild type and Wrn helicase mutant mouse embryonic fibroblasts.
This table is listing the common significant genes altered in the same
direction in Wrn mutant and wild type mouse embryonic fibroblasts. The
primers used for the real time RT-PCR analyses are shown in the
additional file 3.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
127-S3.XLS]
Additional file 4: Primers used for real time RT-PCR. This table
contains the sequence of the oligonucleotides that were used for the
real time RT-PCR with the reaction conditions. Complete results of
microarray analyses are found in additional files 1, 2, 4, and 5.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
127-S4.XLS]
Additional file 5: Differential expression profile between wild type
and Wrn helicase mutant mouse embryonic fibroblasts. This table is
listing the genes altered more than 2 times with a Benjamini-Hochberg
adjusted p-value lower than 0.1 while comparing the Wrn mutant versus
the wild type mouse embryonic fibroblasts. Complete results of
microarray analyses are found in additional files 1, 2, 4, and 5.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
127-S5.XLS]
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